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Predicting effects of blood flow rate and size of
vessels in a vasculature on hyperthermia






Background: Pennes Bio Heat Transfer Equation (PBHTE) has been widely used to approximate the overall
temperature distribution in tissue using a perfusion parameter term in the equation during hyperthermia
treatment. In the similar modeling, effective thermal conductivity (Keff) model uses thermal conductivity as a
parameter to predict temperatures. However the equations do not describe the thermal contribution of blood
vessels. A countercurrent vascular network model which represents a more fundamental approach to modeling
temperatures in tissue than do the generally used approximate equations such as the Pennes BHTE or effective
thermal conductivity equations was presented in 1996. This type of model is capable of calculating the blood
temperature in vessels and describing a vasculature in the tissue regions.
Methods: In this paper, a countercurrent blood vessel network (CBVN) model for calculating tissue temperatures has
been developed for studying hyperthermia cancer treatment. We use a systematic approach to reveal the impact of a
vasculature of blood vessels against a single vessel which most studies have presented. A vasculature illustrates branching
vessels at the periphery of the tumor volume. The general trends present in this vascular model are similar to those
shown for physiological systems in Green and Whitmore. The 3-D temperature distributions are obtained by solving the
conduction equation in the tissue and the convective energy equation with specified Nusselt number in the vessels.
Results: This paper investigates effects of size of blood vessels in the CBVN model on total absorbed power in the
treated region and blood flow rates (or perfusion rate) in the CBVN on temperature distributions during
hyperthermia cancer treatment. Also, the same optimized power distribution during hyperthermia treatment is
used to illustrate the differences between PBHTE and CBVN models. Keff (effective thermal conductivity model)
delivers the same difference as compared to the CBVN model. The optimization used here is adjusting power
based on the local temperature in the treated region in an attempt to reach the ideal therapeutic temperature of
43°C. The scheme can be used (or adapted) in a non-invasive power supply application such as high-intensity
focused ultrasound (HIFU). Results show that, for low perfusion rates in CBVN model vessels, impacts on tissue
temperature becomes insignificant. Uniform temperature in the treated region is obtained.
Conclusion: Therefore, any method that could decrease or prevent blood flow rates into the tumorous region is
recommended as a pre-process to hyperthermia cancer treatment. Second, the size of vessels in vasculatures does
not significantly affect on total power consumption during hyperthermia therapy when the total blood flow rate is
constant. It is about 0.8% decreasing in total optimized absorbed power in the heated region as g (the ratio of
diameters of successive vessel generations) increases from 0.6 to 0.7, or from 0.7 to 0.8, or from 0.8 to 0.9. Last, in
hyperthermia treatments, when the heated region consists of thermally significant vessels, much of absorbed
power is required to heat the region and (provided that finer spatial power deposition exists) to heat vessels which
could lead to higher blood temperatures than tissue temperatures when modeled them using PBHTE.
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Hyperthermia is used to raise tissue temperatures in a
range of 40-43°C for a long period of time to kill tumor-
ous cells. Within the past 20 years, it has gained much
of attention for combining direct thermal toxicity and
enhancements of the efficacy of some drugs [1-3]. The
application of hyperthermia has been integrated in mul-
timodal treatment strategies in several forms of tumors.
Experimental and clinical evidence has indicated that
the combination of cytotoxic drugs with localized
hyperthermia in the cancer treatment increases the kill-
ing of tumor cells [4]. As well as other treatment modal-
ities, they also showed an increasing efficiency in
treatments [5].
The Pennes [6] bio-heat transfer equation (PBHTE)
has been a standard model for predicting temperature
distributions in living tissues for more than half a cen-
tury now. The equation was established through con-
ducting a sequence of experiments of temperature
measurements of tissue and arterial blood temperatures
in the resting human forearm. The equation includes a
special term that describes the heat exchange between
blood flow and solid tissues. The blood temperature is
assumed to be constant arterial blood temperature.
Some researchers [7-11] also developed alternative equa-
tions having the same goal, attempting to formulate a
single, general field equation that could predict the over-
all characteristics of temperature distributions in tissues.
For example, Keff model (effective thermal conductivity
model) [9,11] is a field equation using thermal conduc-
tivity as a key parameter to replace blood perfusion
term in PBHTE. However, this has been challenged by
many research groups internationally when trying to
predict temperature distribution in regions which
involve isolated large vessels.
Those approximate field equations neither have, nor
were they ever intended to have, the ability to accurately
model the effects of isolated, large vessels. Such infre-
quently occurring vessels cannot be simulated by such
approximate field equations, which are intended to pre-
dict the average thermal behavior of the tissue. Thus,
such vessels must be modeled using separate equations.
The effect of such vessels have been studied by Chato
[12] and Huang et al. [13,14] who developed analytical
models for single vessels, and by other investigators
[15-23] who have done numerical and experimental
hyperthermia studies of single vessels and/or counter
current vessel pairs imbedded in either a purely conduc-
tive media (with either a normal thermal conductivity,
or an enhanced, effective thermal conductivity) or in
media modeled by the Pennes BHTE. One of those stu-
dies, by Rawnsley et al. [22], compares the predictions
from such a combined model (approximate field
equation plus a separate blood vessel model) with
experimental hyperthermia results. It clearly showed the
increased accuracy of such combined models. Leeuwen
et al. [23] also stressed that efforts to obtain information
on the positions of the large vessels in an individual
hyperthermia patient will be rewarded with a more
accurate prediction of the temperature distribution.
Finally, a few studies have modeled the effect of collec-
tions of a large number of parallel vessels or of networks
of vessels [23-26].
The present paper describes effects of, blood flow
rates and size of vessels in a vasculature, on 3-D tem-
perature distributions and absorbed power distributions
using a model [24] comprising a network of blood ves-
sels applied with an optimization to reach the ideal ther-
apeutic temperature distribution of uniform 43°C during
hyperthermia cancer treatment. This paper uses a rather
simple, generic vessel network model in order to
develop and illustrate the basic approach of the thermal
model, and to illustrate the types of applications possible
for such a model.
Methods
Vessel Network Geometry and Fully Conjugated Blood
VesselNetwork Model
The geometry used consists of a regular, branching ves-
sel network, as partially shown in (only schematic of the
p a r t i a la r t e r i a lv e s s e ln e t w o r k )F i g u r e1 ( a ) ,t h a ti s
embedded in a control volume which is an (approxi-
mate) cube of dimensions L =8 2m ma n dW = H =8 0
mm in the x, y,a n dz directions, respectively. All seven
vessel levels (level 1 to level 7) are shown. The venous
network is parallel to the arterial network. All vessels
are straight-line segments parallel to one of the three
Cartesian axes. There are up to seven levels of arteries,
beginning with the main artery (level one) which lies
along the central, lengthwise (x) axis of the cube. Table
one of [24] listed the basic vessel network properties
used in these studies. The diameters of the arteries
decrease by a constant ratio g between successive levels






where Di and Di+1 are the diameters of two successive
levels of branching arteries.
When two successive levels of numbered vessels do
not branch but only change direction (i.e., levels six and
seven in this model) the vessel diameter does not
change. Figure 1 (b) shows a transparent view of a paral-
lelepiped indicating internal heated tumor region (or
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Page 2 of 16Figure 1 (a) Schematic of the partial arterial vessel network. All seven vessel levels (level 1 to level 7) are shown. The venous network is
parallel to the arterial network. (b) A transparent view of a parallelepiped showing the internal heated tumor region, which is a cubic volume of
20 mm by 20 mm by 20 mm. The level 1 largest blood vessel is running through the volume’s edge from location (42, 40, 40) mm to location
(62, 40, 40) mm. The original point is located at the southeastern corner when facing the x = 0 plane. (c) The locations of the cubic volume in a
parallelepiped by indicating its 8 corners’ coordinate. The units are millimeters (mm).
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40, 40) mm (at center of inlet boundary plane) to (42,
40, 40) mm which is a branching location point from
level 1 artery vessel to level 2 artery vessels (along z-
axis). The units of coordinates are mm. The location
point, (42, 40, 40), is also a corner of heated tumor
region (or cell) as an enlarged view shown in Figure 1
(c). The tumor has a cubic volume of 20 mm by 20 mm
by 20 mm, which volume is illustrated by its 8 corner
locations. A passing level 1 artery vessel (carries with
0.1% of whole control volume blood perfusion) is
shown, in Figures 1(a) and 1(b), from the branching
location (42, 40, 40) to the exit point (82, 40, 40) of out-
let boundary plane. Thus the passing level 1 artery con-
tributes rather insignificant heat exchange with
surrounding tissues. Figure 1(c) also shows the pathway
of partial arterial branching vessels on the margin of the
tumor and the pathway consists of the level 1 vessel seg-
ment (from (42,40,40) to (62,40,40)), the level 2 vessel
segment (from (42,40,40) to 42,40,60)), the level 3 vessel
segment (from (42,40,60) to (42,60,60)), the level 4 ves-
sel segment (from (42,60,60) to (62,60,60)), the level 5
vessel segment (from (42,60,60) to (42,60,50)) and the
level 6 vessel segment (from (42,60,50) to (42,50,50)).
The locations (42, 60, 50) and (42, 50, 50) are not cor-
ners of the heated tumor volume and they are not
shown in Figure 1(c). The level 1 vessel branching point
at (42, 40, 40) and all its subsequent branching vessels
to lower level vessels present identical pattern for the
branching point at (2, 40, 40) and all its subsequent
branching vessels to lower level vessels. In other words,
the tumor cell resides on the location ranging from (42
to 62, 40 to 60, 40 to 60) of (x, y, z) coordinates and all
other vessels (arterial part) around the cell are high-
lighted in Figure 1(a).
The geometric arrangement of the counter current
veins is essentially identical to that of the arteries, with
all of the veins offset from the arteries by one finite dif-
ference node in x, y, and z as appropriate to avoid inter-
sections of vessels. Each of terminal arteries is assumed
to supply all of the blood to a defined subvolume of tis-
sue and tumor regions which subvolume was defined
according to Figure 2(a) of Huang et al [24].
To better comprehend the results of temperature and
optimized power fields with complicated branching
artery and vein vessels, five detailed vasculature cross-
section planes are shown in Figures 2(a)-2(c) to illus-
trate countercurrent artery-vein vessels pathways and
locations. Figure 2(a) shows arterial branching vessels at
the x = 42 mm cross-section plane. Red dash-dot square
lines indicate the heated region, and Figure 2(b) shows
arterial branching vessels at the x = 52 mm and 62 mm
cross-section planes. Figure 2(c) shows branching coun-
tercurrent artery-vein pair vessels running in the x
Figure 2 (a) The branching vessels at the x = 42 mm cross-
section plane. Red dash-dot square lines indicate the heated
region. (b) The branching vessels at the x = 52 mm and 62 mm
cross-section planes. Red dash-dot square lines indicate the heated
region. (c) The branching countercurrent artery-vein vessels run in x
direction at the x = 38 mm and 66 mm cross-section planes.
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planes which are not in the heated region.
CBVN is a fully conjugated blood vessel network
model formulation which describes the solid tissue
matrix having thermally significant vessel generations
(seven levels). The effects of all vessels smaller than the
terminal (level seven) vessels are not explicitly modeled
in CBVN. Thus, those smaller vessels (connected to the
terminal arteries and the terminal veins in the network)
are implicitly assumed to be thermally insignificant in
the CBVN. Details of the model were described in
Huang et al [24].
Mathematical equations for the thermal model
The governing equations for both tissues and vessels are
described below, the PBHTE for calculating tissue tem-
peratures is:.
     ( (,,) ) ((,,) ) k Txyz wc Txyz T q bb a s 0 (2)
where k, cb, wb, and qs are thermal conductivity of soft
tissue, specific heat of blood, blood perfusion rate and
absorbed thermal power density, respectively. The meta-
bolism effect is neglected in Eqn. (2) due to its limited
effect on temperature distribution during hyperthermia.
The convective energy equation is solved for blood tem-




N u k T xyz T xyz q R bi b b w b s b vi , ,
(,,)
( (,,) (,,) )    
2 (3)
where mb, i is the blood mass flow rate at the level i
vessel segment and si is a coordinate along the axis of
the level i vessel segment. Nu, kb, Rbv, i and Tw are Nus-
selt number, thermal conductivity in blood, radius of
blood vessel at level i and blood vessel wall temperature,
respectively. A total of 682 vessels in the model need to
be calculated using Eqn. (3). Special treatments of perfu-
sion and collecting blood (to and from subvolumes) on
terminal ends (arteries and veins) are added to Eqn. (3)
for level 7 vessel calculations. In all cases studied in the
present paper, the true tissue perfusion ( P
 )w a s
assumed to be uniform everywhere, i.e., PP tsv i

,  for
I = 1-128 (the subscript tsv indicates terminal subvo-
lume in the control volume). It is the same blood perfu-
sion unit as wb described in PBHTE.
Additionally, a simple Keff model is described in Eqn.
(4). That is,
   () KTq eff s 0 (4)
where Keff is an effective conductivity tenor, T is tem-
perature field and qs is absorbed thermal power.
Optimization scheme
The procedure to continuously adjust power deposition
in hyperthermia cancer treatment in order to reach
ideal temperature (uniform temperature of 43°C
throughout the volume of the tumorous region) is
described below.
1. Set initial power field equal to 10
5 W/m
3 uniform
in the treated region.
2. Solve governing equations in tissue and blood
temperature distributions with given boundary con-
ditions and inlet temperatures of vessels, which are
all set to be 37°C.
3. Compare predicted temperature field with ideal
temperature field (which is uniform temperature
throughout the tumor volume) and calculate criteria
value expressed below in Eqn. (5).
4. If criterion value does not meet the condition
described in Eqn. (5), power is updated according
local temperature as it is described below in Eqn.
(6). Go to step 2 and continue the loop.
5. If the criterion meets the condition, the optimal
power and temperature distributions are obtained.
The criterion of power deposition theoretically is
described in Eq. (5), which states that the root mean
square of difference of ideal temperature (which is set to
be 43°C) and calculated temperature in treated region of
all heated target nodes divided by (43-37)°C reaches less
than the criterion value (is set to be 10% of the tem-
perature difference of (43-37)°C). If the criterion is met,
we have obtained the optimization of absorbed power
such that the estimated temperature distribution is close
to the ideal temperature distribution. Otherwise, power
deposition will be adjusted according to local tempera-
ture, i.e. it is a function of position and temperature.
The readjusted power deposition (Pn +1 )i sd e s c r i b e di n
Eqn. (6). Its unit is the same as qs which are used in












Total number of target nodes
(5)
P xyz P xyz pxyz n n+1(,,) (,,) (,,)   (6)
where Δ p(x, y, z) = Coef · ΔT(x, y, z), Coef is 10000, n
is the iteration number and ΔT(x, y, z) is the difference
of ideal temperature (43°C) and calculated temperature.
Smaller Coef values cause more repetitive loops in
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ture distribution. In other words, much more time is
required to process the optimization. If the power
deposited on a site that causes temperature in tissue
raised over 43°C, the power will readjust its power
deposition to a smaller one in the scheme for an ideal
temperature distribution.
Numerical Methods
The numerical scheme used to calculate the temperatures
was a black and red finite difference SOR method [27],
with upwind differencing used for the vessels. The
numerical details are described by Chen [28] and Huang
[14]. Special algorithms were used to account for the ves-
sel corners where arteries and veins change direction, and
where two or more arteries divide, or two or more veins
join. The thermal resistances around the circular vessels
were calculated using the logarithmic resistance approach
as described by Chen and Roemer [29]. The property
values used in treated tumorous and non-treated normal
tissues were kt =0 . 5W/m
3/°C,c=cb = 4000 J/kg/°C and
r =1 0 0 0k g / m
3. The vessel heat transfer coefficient (h)
was calculated using a constant Nusselt number of
four (4) for all vessel levels. In all cases, a finite difference
nodal spacing of 2 mm was used. Test results with a
nodal spacing of 1 mm for test cases using either the
arterial vessel network (when no veins are present) or the
counter current vessel network showed no significant dif-
ferences with the results of the comparable 2-mm nodal
spacing models. This 2-mm spacing gives an inter-vessel
centerline-to-centerline diagonal spacing of 2.8 mm for
the counter current vessels due to the 2-mm offsets in
x, y,a n dz. The blood temperature in vessels was calcu-
lated using a steady uniform velocity profile for blood
flow that has been used widely and accepted in many
investigations. Recently Horng et al [30] reconfirmed it.
The boundary condition for temperature in the control
volume is 37°C for all surfaces of the parallelepiped.
So are the inlet temperatures for level 1 artery and vein.
Results
Testing of this vascular network model has been done
by several means [14] including: a check of the single-
vessel numerical results (all vessels removed except the
level one artery) against an analytical solution; a verifica-
tion that all temperatures vary linearly with the applied
power; and a check that for all results presented in this
paper that the overall energy balance on the control
volume was accurate to within 0.1 percent. Figure 3 of
[24] shows the vessel diameters, total surface areas, and
velocity distributions (for P
 = 0.5) as a function of the
vessel level. The general trends present in that figure are
similar to those shown for physiological systems in
Green [31] and Whitmore [32].
Figures 3(a), (b), (c), (d) and 3(e) show typical tem-
perature predictions using PBHTE. That is, no blood
vessels structure present and temperature distributions
at the x =3 8m m( 4m ma w a yf r o mt h ef r o n tb o u n d -
ary), x = 42 mm (the front boundary), x = 52 mm (mid-
dle of the treated region), x = 62 mm (the back
boundary), and x=6 6m m( 4m ma w a yf r o mt h eb a c k
boundary) planes, respectively, with perfusion rate of 0.5
kg· m
-3s
-1 and optimized power shown in Figures 4(a),
(b), (c), (d) and 4(e). No power is used on Figures 4(a)
and 4(e), which are outside of the treated zone. There
are, respectively, 6 levels of iso-temperature and iso-
power contours, shown in Figures 3, 4, 5 and 6. From
low to high (six) levels, the temperature (°C) set is 38,
39, 40, 41, 42 and 43} and the power (Wm
-3)s e ti s
{30,000, 60,000, 90,000, 120,000, 150,000 and 180,000.
The treated cubic volume (20 mm by 20 mm by 20
mm) is applied with the optimized power. Temperature
distributions inside the treated region illustrated in Fig-
ures 3(b), (c) and 3(d) show very uniform temperature
fields, with an average temperature of about 43°C. Tem-
perature distributions in Figures 3(a) and 3(e) at the
plane 4 mm away from the boundary of the treated
region show maximum temperatures of about 41°C and
40.8°C, respectively. It is about 2°C difference from ideal
therapeutic temperature. The temperature distributions
are calculated by PBHTE with a perfusion rate of 0.5 kg·
m
-3s
-1. Figure 4(b) shows optimized power at the front
boundary plane. Much of the power is focused on the
corners and edges of the treated region to compensate
for thermal energy loss through conduction. Figure 4(d)
shows optimized power at the back boundary plane. It
indicates a power pattern identical with that shown in
Figure 4(b). The optimized power in the middle plane of
the treated region (Figure 4(c)) shows relatively less
power deposited on corners and center area, as com-
pared to the boundary planes. It illustrates the thermal
diffusion rate is relatively small at this plane. The ideal
temperature is set to be 43°C. Figures 4(a) and 4(e) indi-
cate no power absorbed at the two planes.
Figures 5(a), (b), (c), (d) and 5(e) show temperature
predictions using CBVN. That is, with blood vessels
structure present and temperature distributions at the
x =3 8m m( 4m ma w a yf r o mt h ef r o n tb o u n d a r y ) ,x =
42 mm (the front boundary), x = 52 mm (middle of the
treated region), x = 62 mm (the back boundary), and x=
66 mm (4 mm away from the back boundary) planes,
respectively, with perfusion rate of 0.5 kg· m
-3s
-1 and
applied identical absorbed power shown in Figures 4(a),
(b), (c), (d) and 4(e). To illustrate the discrepancy of the
three models (PBHTE, CBVN and Keff), the temperature
prediction at those identical locations using a simple
Keff model with optimized absorbed power (similar to
those graphs shown in Figures 4(a), (b), (c), (d) and 4(e))
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Page 6 of 16Figure 3 (a), (b), (c), (d) and (e) show no blood vessel structure present and temperature distributions at the x = 38 mm (4 mm away
from the front boundary), x = 42 mm (the front boundary), x = 52 mm (middle of the treated region), x = 62 mm (the back
boundary), and x = 66 mm (4 mm away from the back boundary) planes, respectively, with perfusion rate of 0.5 kg· m
-3s
-1 and
optimized power shown in Figure 4(a), (b), (c), (d) and (e).
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Page 7 of 16Figure 4 (a), (b), (c), (d) and (e) showed optimized power distributions at the corresponding plane locations of Figure3. No power is
used in Figs. 4(a) and (e), which are outside of the treated zone. There are, respectively, 6 levels of iso-temperature and iso-power contours,
shown in Figures 3, 4, 5 and 6. From low to high (six) levels, the temperature (C) set is {38, 39, 40, 41, 42 and 43} and the power (Wm
-3) set is
{30,000, 60,000, 90,000, 120,000, 150,000 and 180,000}.
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study, a simple scalar Keff (effective conductivity model)
is used. The value of effective conductivity is 0.5 W/m
3/
°C which is the same as thermal conductivity of tissue
(Keff/Kt = 1), and it also is the same as thermal conductiv-
ity of blood.
With the applied optimized absorbed power distribu-
tions for the case of PBHTE model (without vessels
structure) identical to those in the case of CBVN (with
vessels structure present), temperature distributions in
Figures 5(a) and 5(e) at the plane 4 mm away from the
boundary of the treated region show maximum tem-
peratures of about 39°C and 39.6°C, respectively. It is
about 4°C different from ideal therapeutic temperature.
Figures 5(b), (c) and 5(d) show maximum temperatures
of about 40.9, 41.3 and 41.3°C, respectively. An obvious
cooling effect from the vasculature appears on the fig-
ures. From the temperature distributions, irregular iso-
temperature contours indicate significant impact by
blood vessels. Cold spots and significant cooling effects
of mass flow rate by vessels at the periphery of the
tumor volume present vital characteristics in the model.
These are consistent with many clinical and experimen-
tal phenomena. Unsuccessful hyperthermia treatments
lead to survival of cancerous tissues. Insufficient net
absorbed thermal energy in localized tissue area is one
of the major problems. Figures 6(a), (b), (c), (d) and 6(e)
display similar temperature distributions of PBHTE
using Keff model approach which shows a uniform and
smooth temperature field.
Figure 7(a) shows more than double the power is
needed for the CBVN model as compared to PBHTE
model for the total power absorption in treated tumor
region after optimization. PBHTE is the case with no
blood vessels present. Both cases have the same blood
perfusion rate, however CBVN presents a vasculature
that carries blood flow from a main vessel (level 1) into
branching vessels and, at the terminal ends, perfused
blood to tissues. Therefore, a blood flow rate of about
320 mm/sec in level 1 artery and vein vessels enables
t h eb l o o dt op e r f u s ei n t ot i s s u e sw i t har a t eo f0 . 5k g ·
m
-3s
-1. The perfusion rate of 0.5 kg· m
-3s
-1 in tissues is a
perfusion term parameter which is used for PBHTE. Fig-
ure 7(b) shows the comparison of optimal temperatures
along level 5 and level 6 vessel segments at middle
plane of the heated region (arterial route: from 0 to 0.02
m; veinous route: from 0.02 to 0) in case of CBVN
model (level5-6a represents arterial path consists of level
5 and level 6 vessels; level5-6v represents veinous path
consists of level 5 and level 6 vessels) and those tem-
peratures in case of PBHTE model (level5-6a PBHTE
represents those arterial path locations which are calcu-
lated via PBHTE instead of CBVN; level5-6v PBHTE
represents those veinous path locations which are
calculated via PBHTE instead of CBVN). Figure 7(c)
shows lengthwise axis (indicated by a dash line) from
the intersection of level 3-4-5 vessels to the level 6-7
intersection at the middle plane of heated region shown
in Figure 2(a).
Figure 8 shows (a), (b), (c) and (d), the temperature
distributions by CBVN at x = 42 mm, the front bound-
ary plane (Figure 2(a)), for low perfusion rates of 0.5,
0.1, 0.05 and 0.01 kg· m
-3s
-1, respectively. Figures 8(e),
(f), (g) and 8(h) are their optimized absorbed power dis-
tributions, respectively. Higher magnitudes of absorbed
power are located on or near vessels. As perfusion
decreases, magnitude of optimized power on vessels
decreases. Figure 8(h) shows very small and uniform
power distribution in the heated region as perfusion
reaches 0.01 kg· m
-3s
-1.A ss h o w ni nF i g u r e s8 ( f )a n d8
(g), an increase of perfusion rate in the heated region
makes level 2 vessels significant, because vessels gain
higher blood speeds and require more power to heat the
fluid. On the other hand, strong temperature perturba-
tion caused by vessels’ convection effect has significantly
dampened as blood perfusion decreases. In Figure 8, the
legend from low to high levels, the temperature (°C) 13-
level set is 37, 37.5, 38, 38.5, 39, 39.5, 40, 40.5, 41, 41.5,
42, 42.5 and 43} and the power (Wm
-3) 15-level set is
{3.0e4, 2.3e5, 4.3e5, 6.3e5, 8.3e5, 1.0e6, 1.2e6, 1.4e6,
1.6e6, 1.8e6, 2.0e6, 2.2e6, 2.4e6, 2.6e6 and 2.8e6}.
Figure 9 shows total optimized absorbed power in the
heated region versus the ratio of diameters of successive
vessel generations (g) in the vasculature of the region
with perfusion rate of 0.5 kg· m
-3s
-1.A sg increases from
0.6 to 0.7, it indicates diameters of successive vessel gen-
erations are bigger. The total power required to heat the
tumor volume decreases from 2.387 to 2.366. This is
about 0.8% decrease in total optimized absorbed power
in the region. There is approximately the same trend for
g that increases from 0.7 to 0.8, and from 0.8 to 0.9.
Discussion
As PBHTE has been widely used in predicting overall
temperature behaviors in tissue for many studies, mista-
ken prediction occurs, when in practicality, a vasculature
with thermally significant vessels exists in or near the
treated region. As shown in Figures 3 and 4, considering
the treated region to be homogenous and without any
vascular effect, we modeled it as a PBHTE (or Keff
model) with some perfusion rate parameter. We then
obtained the prediction of optimal absorbed power field
for the assumed treated region. However, if in fact the
region has a vasculature with thermally significant ves-
sels, we clinically or experimentally applied the pre-
dicted optimal power field in the treated region.
Therefore undercooling effect by vessels to the ideal
temperature results as illustrated in Figure 5(a). In
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Page 9 of 16Figure 5 (a), (b), (c), (d) and (e) show with blood vessel structure present and temperature distributions at the x = 38 mm (4 mm
away from the front boundary), x = 42 mm (the front boundary), x = 52 mm (middle of the treated region), x = 62 mm (the back
boundary), and x = 66 mm (4 mm away from the back boundary) planes, respectively, with perfusion rate of 0.5 kg· m
-3s
-1. The
applied absorbed power distributions are the identical optimized power distributions shown in Figs. 4(a), (b), (c), (d) and (e) for the case of
PBHTE.
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Page 10 of 16Figure 6 (a), (b), (c), (d) and (e) showed temperature distributions using a simple Keffmodel at the corresponding plane locations with
optimal absorbed power. There are, respectively, 6 levels of same iso-temperature and iso-power contours shown in Figures 3, 4, 5 and 6.
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Page 11 of 16Figure 7 (a) Case Comparison for Total Power Absorption in Treated Tumor Region after Optimization.P B H T Ei st h ec a s ew h e nn o
blood vessel presents. And the case of CBVN has the same blood perfusion rate as the PBHTE case but includes a network of vessels which
reveal blood flow rate about 320 mm/sec in level 1 artery and vein vessels. The perfusion rate of 0.5 kg/(m
3s) in tissues which are perfused by
blood vessels is used for PBHTE. 7(b) The comparison of temperatures along level 5 and level 6 vessel segments after optimization at middle
plane of the heated region (arterial route: from 0 to 0.02 m; veinous route: from 0.02 to 0) in case of CBVN model (level5-6a represents arterial
path consists of level 5 and level 6 vessels; level5-6v represents veinous path consists of level 5 and level 6 vessels) and those temperatures in
case of PBHTE model (level5-6a PBHTE represents those arterial path locations which are calculated via PBHTE instead of CBVN; level5-6v PBHTE
represents those veinous path locations which are calculated via PBHTE instead of CBVN). 7(c) Lengthwise coordinate (indicated by a dash line)
from the intersection of level 3-4-5 vessels to the level 6-7 intersection at the middle plane of heated region shown in Fig. 2(a)
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Page 12 of 16Figure 8 (a), (b), (c) and (d) show the temperature distributions at the x = 42 mm, the front boundary plane (the level 2 branching
vessel plane), for low perfusion rates of 0.5, 0.1, 0.05 and 0.01 kg· m
-3s
-1, respectively. (e), (f), (g) and (h) show their optimized absorbed
power distributions, respectively. From low to high levels, the temperature (C) 13-level set is {37, 37.5, 38, 38.5, 39, 39.5, 40, 40.5, 41, 41.5, 42, 42.5
and 43} and the power (Wm
-3) 15-level set is {3.0e4, 2.3e5, 4.3e5, 6.3e5, 8.3e5, 1.0e6, 1.2e6, 1.4e6, 1.6e6, 1.8e6, 2.0e6, 2.2e6, 2.4e6, 2.6e6 and 2.8e6}.
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Page 13 of 16present results, cold strips, heterogeneous temperature
spots and significant cooling effects by vessels in the
treated region present vital characteristics in the CBVN
model. These phenomena reveal the similar critical
situations during treatments. Mostly, unsuccessful
hyperthermia treatments lead to survival of cancerous
tissues. Thus, insufficient net absorbed thermal energy
in localized tissue area is one of the major problems.
Furthermore, the presented results indicated an ideal
case of complete absorbed thermal power in blood
which usually generates attenuation in absorbing power
(e. g. ultrasound power).
Figure 7(a) shows that the difference in total opti-
mized absorbed power between two models: a tradi-
tional bio-heat transfer equation (PBHTE) and the
CBVN model. The CBVN model requires more
absorbed power to heat the blood fluid in the treatment
to reach the ideal therapeutic temperature due to
vessels entering with lower inlet (to treated volume)
temperatures. The required absorbed power is about
twice of the value of that in the PBTHE case. To reveal
detailed temperature discrepancy in the two models, the
lengthwise vessel locations containing level 5 and level
6 vessel segments at middle plane of heated region are
chosen to compare those locations when using PBHTE
model, that is shown in Figure 7(b). All temperatures in
both models after optimization are in the range of
4 2 - 4 4 ° C .I nC B V Nm o d e l ,b l o o d( i . e .i na r t e r i a lv e s s e l )
has higher temperatures than those (i.e. tissue) locations
when using PBHTE in some locations, since blood has
gained significant absorbed power during treatment. On
the other hand, veinous case does not have large tem-
perature difference than arterial one. One of reasons is
that veinous vessels collecting blood from surrounding
tissue temperatures which were well heated under
treatment.
Figure 9 Total optimized absorbed power in the heated region versus the ratio of diameters of successive vessel generations (g)i n
the vasculature, when the region’s perfusion rate is 0.5 kg· m
-3s
-1.
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Page 14 of 16Additionally from Figures 8(e) and 8(f), they indicated
that much of the power absorbed in the treated region
after optimization is focused on (or near) blood vessels
or dense vessel area. This power optimization scheme
offers finer spatial power resolution. A non-invasive heat
transducer such as high-intensity focused ultrasound
(HIFU) has great potential to perform the optimization
scheme. Therefore, uniform ideal temperature is possi-
bly reached throughout the treated region except for
some cold spots due to significant vessels near the
tumor boundary.
As the perfusion in the treated region decreases, the
hyperthermia treatment improves significantly, as shown
in the temperature distributions (Figures 8(a)-(d)). Tem-
perature fields show more uniformity in the region as
blood flow rate becomes smaller. That is, less tempera-
ture perturbation caused by vessels. These results show
a systematic approach to reveal the impact of a vascula-
ture of blood vessels against a single vessel which most
studies have presented. Cold strips and cold spots are
significantly reduced and/or disappear. Given those low
perfusion rates of 0.5, 0.1, 0.05 and 0.01 kg· m
-3s
-1 (Fig-
ure 8(a)-(d)) in the region with a vasculature, the blood
flow speeds of level 1 branching vessel are calculated,
and they are approximately 320, 64, 32 and 6 mm/s for
those perfusion rates, respectively. This result suggests
that reducing or preventing blood flow rate flowing into
vasculature(s) of the tumorous treated region is helpful
to the treatment. The magnitude of power is reduced as
well when perfusion rate decreases.
As the results show in Figure 9, total optimized
absorbed power in the heated region does not signifi-
cantly change total power as the ratio of diameters of
successive vessel generations increases from 0.6 to 0.9.
Every increment of 0.1 of g in the range of 0.6 to 0.9
only causes about 0.8% decrease of total absorbed
power. Thus, it suggests the size of vessels in vascula-
ture does not significantly affect total power consump-
tion during treatments provided that constant perfusion
rate at the region. For example, several thermally signifi-
cant vessels and their blood flow rates are identified in
the treated region; the size of diameters of vessels does
not affect much the total absorbed power in the treat-
ment thereafter. This helps in simplifying hyperthermia
treatment process once the locations and blood flow
rates of thermally significant vessels are identified.
Conclusion
In summary, these studies suggest that first, any medical
strategy that could decrease or prevent blood flow rates
into the tumorous region is recommended as a pre-pro-
cess to hyperthermia cancer treatment or thermal sur-
gery. Second, the size of vessels in vasculatures does not
significantly affect on total power consumption during
hyperthermia therapy when the total blood flow rate is
constant. Also, for the presence of thermally significant
vessels in the treated region, particularly with high per-
fusion rate (i.e. greater than 0.5 kg· m
-3s
-1), PBHTE is
not a suitable model to predict the temperature distribu-
tion. Last, in hyperthermia treatments, when the heated
region consists of thermally significant vessels, much of
absorbed power is required to heat the region and (pro-
vided that finer spatial power deposition exists) to heat
vessels which could lead to higher blood temperatures
than tissue temperatures when modeled them using
PBHTE.
Future efforts should be aimed at developing more
accurate and tissue-specific fully conjugated models
which can better predict actual tissue temperatures in
in-vivo situations.
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